Title | A Phase 1b/2, Open-Label, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of SM88 in Patients With Prostate Cancer |
---|---|
Disease/Condition | Prostate Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Neoplasms,Urogenital Neoplasms |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Benjamin Gartrell, MD |
Contact Name | Gina Aracena |
Contact Email | gihernan@montefiore.org |
Protocol Number | 18-06-199-01 |
Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Medical and Hematologic Oncology - Prostate |
Adult, Pediatric, Both | Adult |